Endurant Capital Management’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-13,600	Closed	-$282K	–	95
2017 Q1	$282K	Buy	+13,600	New	+$282K	0.09%	82